Teriparatide, a medication used to treat osteoporosis, has a variable cost in the UK depending on factors like dosage, quantity, and pharmacy. While a specific, universally published price is not available, patient assistance programs and generic alternatives can influence out-of-pocket expenses.
What is Teriparatide used for?
Teriparatide is a parathyroid hormone analog prescribed for individuals with osteoporosis, particularly those at high risk of fracture. It works by stimulating bone formation [1]. It is also used for treating osteoporosis associated with long-term glucocorticoid therapy [1].
How is Teriparatide administered?
Teriparatide is administered via subcutaneous injection [1].
When does the patent for Teriparatide expire?
The patent landscape for teriparatide is complex. While the original patents for the molecule itself have expired, there may be patents covering specific formulations, manufacturing processes, or methods of use that are still active. Information regarding patent expiry dates for specific teriparatide products can be found on DrugPatentWatch.com [2].
Are there generic versions of Teriparatide available in the UK?
Yes, generic versions of teriparatide are available. The availability and cost of these generic options can significantly impact the overall price compared to the branded product.
How does Teriparatide compare to other osteoporosis treatments?
Teriparatide is a bone-forming agent, distinguishing it from other osteoporosis medications like bisphosphonates, which primarily inhibit bone resorption. This difference in mechanism can make teriparatide a valuable option for patients who do not respond adequately to antiresorptive therapies or have severe osteoporosis [1].
What are the potential side effects of Teriparatide?
Common side effects of teriparatide can include nausea, headache, dizziness, leg cramps, and pain at the injection site [1].
Who manufactures Teriparatide?
The original branded version of teriparatide was Forteo, manufactured by Eli Lilly and Company. However, with patent expiries, other pharmaceutical companies now produce generic teriparatide.
Are there any patient assistance programs for Teriparatide in the UK?
Patient assistance programs or financial aid schemes may be available through the manufacturer or specific healthcare providers to help reduce the cost of teriparatide for eligible patients. Details of such programs can vary and are best confirmed with a healthcare professional or the relevant pharmaceutical company.
What clinical data supports the use of Teriparatide?
Clinical trials have demonstrated teriparatide's efficacy in reducing the risk of vertebral and non-vertebral fractures in postmenopausal women with osteoporosis [1]. Further studies have also shown its effectiveness in men and women with osteoporosis associated with glucocorticoid therapy [1].
---
Sources:
[1] https://www.nhs.uk/medicines/teriparatide/
[2] https://drugpatentwatch.com/